Image For Activity Cover
Late-Breaking Clinical Trials - All About AFib
Description

Join us as we square off with our great challenge, finding better management solutions for our AFib patients.  

Scheduled Interactive Session
Meet the Trialists: 11:00 AM EDT, Saturday May 9, 2020
To attend the scheduled sessions, please log in to Heart Rhythm 365.

Presentations

Moderator            Fred M. Kusumoto, MD, FHRS
                              Mayo Clinic Jacksonville, EP and Pacing Services, Jacksonville, FL

Commentators    Christine M. Albert, MD, MPH, FHRS
                              Cedars Sinai Medical Center, Los Angeles, CA 
           
                              Isabelle C Van Gelder, MD, PhD
                              University Medical Center Groningen, Groningen, Netherlands

LBCT & Submitting Authors

Improving Esophageal Protection During AF Ablation With Ablation Index Technology: Outcomes From The Impact Study.
Mark M. Gallagher, MD, St George's Hospital Medical School, London, United Kingdom


Incidence Of Silent Brain Infarcts In Anticoagulated Patients With Atrial Fibrillation.
David Conen, MD, MPH, McMaster University, Hamilton, ON, Canada


Primary Outcome Evaluation Of A Next Generation Left Atrial Appendage Closure Device: The PINNACLE FLX Trial.
Shephal K Doshi, MD, Pacific Heart Institute, Santa Monica, CA


Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study.
Nazem Akoum, MD, MS, FHRS, University of Washington, Seattle, WA


Active Extracellular Matrix Remodeling Prepares The Heart For Future Atrial Fibrillation. First Results Of The PREDICT-AF Trial.
Joris R. de Groot, MD, PhD, Amsterdam UMC, Amsterdam, Netherlands
Disclosures

F. Kusumoto: Nothing to Disclose                          

C. Albert:   Research (Contracted Grants for PIs and Named Investigators only): Abbott, Roche Diagnostics, St. Jude Medical. Honoraria/Speaking/Consulting Fee: Roche Diagnostics
                            
I. Gelder: Research (Contracted Grants for PIs and Named Investigators only): Medtronic. Honoraria/Speaking/Consulting Fee: BMS/Pfizer Alliance
                             
M. Gallagher: Honoraria/Speaking/Consulting Fee: Medtronic, Cook Medical, Biosense Webster, Inc. Research (Contracted Grants for PIs and Named Investigators only): Attune Medical

D. Conen:  Honoraria/Speaking/Consulting Fee: Survier

S. K Doshi:  Research (Contracted Grants for PIs and Named Investigators only): Biosense Webster, Abbott, Boston Scientific. Honoraria/Speaking/Consulting Fees: Janssen Pharmaceuticals. Employment: Biotronic for Spouse/Parner

N. Akoum: Nothing to Disclose

J. de Groot,:   Research (Contracted Grants for PIs and Named Investigators only): Medtronic. Honoraria/Speaking/Consulting Fee: BMS/Pfizer Alliance
Summary
Availability: On-Demand
Cost: FREE
Credit Offered: No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Powered By